Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients

Breast Journal

Volumn 11, Issue 5, 2005, Pages 311-316

  Kanazawa, Takashi ^a   Akashi Tanaka, Sadako ^a   Iwamoto, Eriko ^a   Takasugi, Miyuki ^a   Shien, Tadahiko ^a   Kinoshita, Takayuki ^a   Miyakawa, Kunihisa ^a   Shimizu, Chikako ^a   Ando, Masashi ^a   Katsumata, Noriyuki ^a   Fujiwara, Yasuhiro ^a   Fukutomi, Takashi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Breast cancer; Complete response; Computed tomography; Diagnostic images; Neoadjuvant chemotherapy

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; TAXANE; TAXOID;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG RESPONSE; ECHOMAMMOGRAPHY; FEMALE; FIBROSIS; GRANULOMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAMMOGRAPHY; MASTECTOMY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; TUMOR VOLUME; ADJUVANT THERAPY; BREAST TUMOR; CANCER STAGING; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DOSE RESPONSE; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; MORTALITY; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; BREAST NEOPLASMS; BRIDGED COMPOUNDS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DIAGNOSTIC IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TAXOIDS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 27744582090     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.00003.x     Document Type: Article

References (13)

1. Buzdar AU, Hunt K, Smith T, et al. Significantly higher pathological complete remission (PCR) rate following neoadjuvant therapy with trastuzumab (H), paclitaxel (P), and anthracycline-containing chemotherapy (CT): initial results of a randomized trial in operable breast cancer (BC) with HER/2 positive disease. J Clin Oncol 2004;22(July 15 Suppl):520. Abstract.
2. Akashi-Tanaka S, Fukutomi T, Watanabe T, et al. Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapy, Int J Cancer 2001;96:66-73.
3. Rosen EL, Blackwell KL, Baker JA, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 2003;181:1275-82.
4. Cheung YC, Chen SC, Su MY, et al. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 2003;78:51-58.
5. Ogawa Y, Nishioka A, Kubota K, et al. CT findings of breast cancer with clinically complete response following neoadjuvant chemotherapy-histological correlation. Oncol Rep 2003;10:1411-15.
6. Mumtaz H, Davidson T, Spittle M, et al. Breast surgery after neoadjuvant treatment. Is it necessary? Eur J Surg Oncol 1996;22:335-41.
7. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-16.
8. Akashi-Tanaka S, Fukutomi T, Sato N, et al. The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery. Ann Surg 2004;239:238-43.
9. Akashi-Tanaka S, Fukutomi T, Miyakawa K, Uchiyama N, Tsuda H. Diagnostic value of contrast-enhanced computed tomography for diagnosing the intraductal component of breast cancer. Breast Cancer Res Treat 1998;49:79-86.
10. Akashi-Tanaka S, Watanabe T, Fukutomi T, et al. Diagnosis of residual breast cancer after neoadjuvant at chemotherapy using contrast-enhanced computed tomography. J Clin Oncol 2001;20(May 12 Suppl):1829. Abstract.
11. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A. Effect of preoperative chemotherapy on the outcome of women with operative breast cancer. J Clin Oncol 1998;16:2672-85.
12. Ring A, Webb A, Ashley S, et al. Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol 2003;21:4540-45.
13. Esserman L, Kaplan E, Partridge S, et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 2001; 8:549-59.